|
1
|
Calin A, Porta J, Fries JF and Schurman
DJ: Clinical history as a screening test for ankylosing
spondylitis. JAMA. 237:2613–2614. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braun J and Sieper J: Ankylosing
spondylitis. Lancet. 369:1379–1390. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gran JT and Skomsvoll JF: The outcome of
ankylosing spondylitis: a study of 100 patients. Br J Rheumatology.
36:766–771. 1997. View Article : Google Scholar
|
|
4
|
Van der Linden S, Valkenburg HA and Cats
A: Evaluation of diagnostic criteria for ankylosing spondylitis. A
proposal for modification of the New York criteria. Arthritis
Rheum. 27:361–368. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Graham B and Van Peteghem PK: Fractures of
the spine in ankylosing spondylitis. Diagnosis, treatment, and
complications. Spine (Phila Pa 1976). 14:803–807. 1989. View Article : Google Scholar
|
|
6
|
Braun J, Brandt J, Listing J, et al:
Treatment of active ankylosing spondylitis with infliximab: a
randomised controlled multicentre trial. Lancet. 359:1187–1193.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Akhtar S, O’Flynn PE, Kelly A and
Valentine PM: The management of dysphasia in skeletal hyperostosis.
J Laryngol Otol. 114:154–157. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imhof H and El-Khoury GY: Traumas of the
Axial Skeleton. Musculoskeletal Diseases. Springer; Milan: pp.
112–120. 2005, View Article : Google Scholar
|
|
9
|
Van der Linden SM, Valkenburg HA, de Jongh
BM and Cats A: The risk of developing ankylosing spondylitis in
HLA-B27 positive individuals. A comparison of relatives of
spondylitis patients with the general population. Arthritis Rheum.
27:241–249. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brown MA, Kennedy LG, MacGregor AJ, et al:
Susceptibility to ankylosing spondylitis in twins: the role of
genes, HLA, and the environment. Arthritis Rheum. 40:1823–1828.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jacobs JC, Berdon WE and Johnston AD:
HLA-B27-associated spondyloarthritis and enthesopathy in childhood:
clinical, pathologic, and radiographic observations in 58 patients.
J Pediatr. 100:521–528. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leirisalo-Repo M: Reactive arthritis.
Scand J Rheumatol. 34:251–259. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Atagunduz P, Appel H, Kuon W, et al:
HLA-B27-restricted CD8+ T cell response to
cartilage-derived self peptides in ankylosing spondylitis.
Arthritis Rheum. 52:892–901. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braun J, Khan MA and Sieper J: Enthesitis
and ankylosis in spondyloarthropathy: what is the target of the
immune response? Ann Rheum Dis. 59:985–994. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brandt J, Haibel H, Cornely D, et al:
Successful treatment of active ankylosing spondylitis with the
anti-tumor necrosis factor alpha monoclonal antibody infliximab.
Arthritis Rheum. 43:1346–1352. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reinherz EL and Schlossman SF: The
differentiation and function of human T lymphocytes. Cell.
19:821–827. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sallusto F, Lenig D, Förster R, Lipp M and
Lanzavecchia A: Two subsets of memory T lymphocytes with distinct
homing potentials and effector functions. Nature. 401:708–712.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lucey DR, Clerici M and Shearer GM: Type 1
and type 2 cytokine dysregulation in human infectious, neoplastic,
and inflammatory diseases. Clin Microbiol Rev. 9:532–562.
1996.PubMed/NCBI
|
|
19
|
Wilke CM, Bishop K, Fox D and Zou W:
Deciphering the role of Th17 cells in human disease. Trends
Immunol. 32:603–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yen HR, Harris TJ, Wada S, et al: Tc17 CD8
T cells: functional plasticity and subset diversity. J Immunol.
183:7161–7168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szalay B, Mészáros G, Cseh Á, et al:
Adaptive immunity in ankylosing spondylitis: phenotype and
functional alterations of T-cells before and during infliximab
therapy. Clin Dev Immunol. 2012:8087242012. View Article : Google Scholar
|
|
22
|
Raffeiner B, Dejaco C, Duftner C, et al:
Between adaptive and innate immunity: TLR4-mediated perforin
production by CD28null T-helper cells in ankylosing spondylitis.
Arthritis Res Ther. 7:R1412–R1420. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin Q, Gu JR, Li TW, et al: Value of the
peripheral blood B-cells subsets in patients with ankylosing
spondylitis. Chin Med J (Eng). 122:1784–1789. 2009.
|
|
24
|
Wu Y, Ren M, Yang R, et al: Reduced
immunomodulation potential of bone marrow-derived mesenchymal stem
cells induced CCR4+CCR6+ Th/Treg cell subset
imbalance in ankylosing spondylitis. Arthritis Res Ther.
13:R292011. View
Article : Google Scholar
|
|
25
|
Kidd P: Th1/Th2 balance: the hypothesis,
its limitations, and implications for health and disease. Altern
Med Rev. 8:223–246. 2003.PubMed/NCBI
|
|
26
|
Yao S, Hong CC, McCann SE, et al: Combined
effects of circulating levels of 25-hydroxyvitamin d and Th1 and
th2 cytokines on breast cancer estrogen receptor status. Cancers
(Basel). 6:211–225. 2014. View Article : Google Scholar
|
|
27
|
Hou N, Zhang X, Zhao L, et al: A novel
chronic stress-induced shift in the Th1 to Th2 response promotes
colon cancer growth. Biochem Biophys Res Commun. 439:471–476. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gut W, Pancer K, Abramczuk E, et al: RSV
respiratory infection in children under 5 y.o - dynamics of the
immune response Th1/Th2 and IgE. Przegl Epidemiol. 67:17–22.
2013.
|
|
29
|
Vitry MA, De Trez C, Goriely S, et al:
Crucial role of gamma interferon-producing CD4+ Th1 cells but
dispensable function of CD8+ T cell, B cell, Th2, and Th17
responses in the control of Brucella melitensis infection in mice.
Infect Immun. 80:4271–4280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Steinman L: A brief history of T(H)17, the
first major revision in the T(H)1/T(H)2 hypothesis of T
cell-mediated tissue damage. Nat Med. 13:139–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yasukawa S, Dainichi T, Kokuba H, et al:
Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2,
Treg and Th17 immunological changes. Eur J Dermatol. 19:69–71.
2009.
|
|
32
|
Bryant C, Suen H, Brown R, et al:
Long-term survival in multiple myeloma is associated with a
distinct immunological profile, which includes proliferative
cytotoxic T-cell clones and a favourable Treg/Th17 balance. Blood
Cancer J. 3:e1482013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gaur P, Qadir GA, Upadhyay S, Singh AK,
Shukla NK and Das SN: Skewed immunological balance between Th17
(CD4(+)IL17A (+)) and Treg (CD4 (+)CD25 (+)FOXP3 (+)) cells in
human oral squamous cell carcinoma. Cell Oncol (Dordr). 35:335–343.
2012. View Article : Google Scholar
|
|
34
|
Iwakura Y, Nakae S, Saijo S and Ishigame
H: The roles of IL-17A in inflammatory immune responses and host
defense against pathogens. Immunol Rev. 226:57–79. 2008. View Article : Google Scholar
|
|
35
|
Cañete JD, Martínez SE, Farrés J, et al:
Differential Th1/Th2 cytokine patterns in chronic arthritis:
interferon gamma is highly expressed in synovium of rheumatoid
arthritis compared with seronegative spondyloarthropathies. Ann
Rheum Dis. 59:263–268. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rudwaleit M, Haibel H, Baraliakos X, et
al: The early disease stage in axial spondylarthritis: results from
the German Spondyloarthritis Inception Cohort. Arthritis Rheum.
60:717–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
